The purpose of this study is to compare the clinical and functional outcomes of patients with mild to moderate arthroscopically confirmed osteoarthritis between the following two groups: 1. Partial fat pad harvest with Adipose-Derived Stem Cell (ADSC) transplantation with standard arthroscopic treatment consisting of: partial meniscectomy, cartilage stabilization, loose body removal and selective synovectomy. 2. Standard arthroscopic treatment (above) without cell transplant.
Adipose-derived stem cells (ADSC) may be beneficial to patients with OA because they may differentiate into chondrocytes, promote endogenous tissue repair, and have potent anti-inflammatory properties. Early studies show promising clinical results using ADSCs to treat patients with osteoarthritis, but no clinical trials have been completed comparing cellular therapy to standard arthroscopic treatment. The investigators aim to determine whether ADSC transplantation as adjuvant therapy in patients with arthroscopic findings of mild to moderate arthritis will result in improved clinical outcomes scores at one and two-year follow-up compared to standard arthroscopic treatment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
29
Autologous fat pad harvest and transplantation of cells after standard arthroscopic treatment consisting of: partial meniscectomy, synovectomy, chondroplasty, loose body removal.
standard arthroscopic treatment consisting of: partial meniscectomy, synovectomy, chondroplasty, loose body removal.
Kerlan Jobe Orthopedic Institute
Santa Monica, California, United States
RECRUITINGStanford University
Stanford, California, United States
ACTIVE_NOT_RECRUITINGUC Health Steadman Hawkins Clinic - Denver Inverness
Denver, Colorado, United States
RECRUITINGPostoperative KOOS (Knee Injury and Osteoarthritis Outcome Score) score 24 months following surgery
Patient reported outcomes measures; Score ranges 0-100, with 100 being healthy/normal
Time frame: The study will end after 24 month follow-up is completed in all participants.
Tegner score
Patient reported outcomes measures
Time frame: 6, 12, 24 months
Lysholm score
Patient reported outcomes measures
Time frame: 6, 12, 24 months
VR-12
Patient reported outcomes measures
Time frame: 6, 12, 24 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.